Cite
HARVARD Citation
Horwitz, S. et al. (2021). Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial. Leukemia & lymphoma. 62 (13), pp. 3109-3118. [Online].